Skip to Content
Merck
  • The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins.

The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins.

Nature communications (2022-04-29)
Georg Petkau, Twm J Mitchell, Krishnendu Chakraborty, Sarah E Bell, Vanessa D Angeli, Louise Matheson, David J Turner, Alexander Saveliev, Ozge Gizlenci, Fiamma Salerno, Peter D Katsikis, Martin Turner
ABSTRACT

CD8+ T cell differentiation into effector cells is initiated early after antigen encounter by signals from the T cell antigen receptor and costimulatory molecules. The molecular mechanisms that establish the timing and rate of differentiation however are not defined. Here we show that the RNA binding proteins (RBP) ZFP36 and ZFP36L1 limit the rate of differentiation of activated naïve CD8+ T cells and the potency of the resulting cytotoxic lymphocytes. The RBP function in an early and short temporal window to enforce dependency on costimulation via CD28 for full T cell activation and effector differentiation by directly binding mRNA of NF-κB, Irf8 and Notch1 transcription factors and cytokines, including Il2. Their absence in T cells, or the adoptive transfer of small numbers of CD8+ T cells lacking the RBP, promotes resilience to influenza A virus infection without immunopathology. These findings highlight ZFP36 and ZFP36L1 as nodes for the integration of the early T cell activation signals controlling the speed and quality of the CD8+ T cell response.

MATERIALS
Product Number
Brand
Product Description

Supelco
Phenobarbital-D5 (side chain) solution, (deuterium label on side chain), 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Pricing and availability is not currently available.
Sigma-Aldrich
Protease Inhibitor Cocktail, for use with mammalian cell and tissue extracts, DMSO solution
Pricing and availability is not currently available.